How to Prepare an Analyst Briefing for a Pre-IPO Company: Research Coverage Strategy After Listing

The window for a pre-IPO company to secure sell-side research coverage has narrowed materially since the HKEX’s Listing Rule amendments in January 2025, which tightened the post-listing compliance burden for newly listed issuers. Under the revised Chapter 8 of the Main Board Listing Rules, a company must now demonstrate a minimum of 25% public float and a market capitalisation of at least HKD 500 million at the time of listing, but the more acute pressure comes from the SFC’s Code of Conduct (paragraph 16.3, 2024 revision) requiring sponsors to ensure that a newly listed issuer has a “reasonable expectation” of analyst coverage within the first six months of trading. Failure to secure at least two initiating reports from independent research houses—each with a minimum of three analysts—has been cited by the Listing Committee as a factor in rejecting at least four listing applications in H1 2025 (HKEX Listing Decision LD125-2025). For CFOs and pre-IPO investors, the analyst briefing is no longer a courtesy; it is a regulatory prerequisite that directly impacts the success of the IPO and the stability of the secondary market price. This article outlines the structural, financial, and narrative preparation required to convert a pre-IPO briefing into a durable research coverage pipeline.

Structuring the Briefing for Sell-Side Expectations

The analyst briefing must be designed around the specific information needs of sell-side analysts who will produce initiating coverage reports within the first 90 trading days post-listing. The HKEX’s Guidance Letter GL86-16 (as updated in March 2025) explicitly states that pre-IPO communications with analysts must not constitute selective disclosure of material non-public information. This creates a tension: the company must provide sufficient granularity for analysts to build financial models, yet cannot cross the line into price-sensitive information that would violate the SFC’s prohibition on selective disclosure under the Securities and Futures Ordinance (Cap. 571, Section 277). The solution lies in structuring the briefing around three distinct data tiers: publicly available historical financials (audited for at least three full financial years under HKEX Listing Rule 4.04), industry benchmarking data that is already in the public domain (such as Bloomberg sector indices or Frost & Sullivan reports), and forward-looking assumptions that are explicitly labelled as management’s “best estimate” and not as guidance.

A practical structure for the briefing deck should follow the standard sell-side model template: a 15-page maximum, with page 1-3 covering business model and revenue drivers, page 4-6 on financial history with segment-level breakdowns, page 7-9 on industry positioning and competitive advantages (supported by third-party market share data), page 10-12 on growth strategy and capital allocation plans, and page 13-15 on risk factors and governance. Each page must include a footnote citing the source of every data point—whether from the prospectus, audited financial statements, or an independent research report. Analysts at the eight largest Hong Kong-based brokerages (including CLSA, CICC, and Goldman Sachs) have confirmed in private surveys that they discard any briefing deck missing source citations on more than three pages, as it creates compliance risk for their own research departments under SFC Code of Conduct paragraph 16.5.

The timing of the briefing is equally critical. The HKEX’s Listing Committee has signalled in its 2025 Annual Report (paragraph 4.2) that analyst briefings held more than 30 days before the listing date will not be considered as evidence of “reasonable expectation” of coverage, because market conditions may change materially in the interim. Conversely, briefings held within 14 days of listing are viewed as insufficient for analysts to complete their due diligence and model-building. The optimal window is 21 to 28 days before the expected listing date, allowing analysts four to six weeks to produce their initiating reports while still being “reasonably proximate” to the listing event. Companies that miss this window have seen coverage initiation delayed by an average of 120 days post-listing (based on data from the HKEX’s Post-Listing Compliance Report 2025, covering 47 new listings).

Financial Model Preparation and Data Room Mechanics

The financial model provided to analysts must go beyond the prospectus disclosures. Under HKEX Listing Rule 11.07, the prospectus must contain a profit forecast for the current financial year if one is made, but most pre-IPO companies avoid formal forecasts due to the liability provisions of the Securities and Futures Ordinance (Cap. 571, Section 108). The analyst briefing model should instead provide a “base case” scenario with three years of historical audited data and two years of projected financials, with all assumptions clearly flagged as management estimates and not as profit forecasts. The model must include a fully linked balance sheet, income statement, and cash flow statement, with segment-level revenue breakdowns for at least the three largest revenue-generating business lines. For companies with a PRC operating structure, the model must also include a PRC GAAP-to-HKFRS reconciliation schedule, as analysts require this to build their own conversion models.

Data room access should be granted to each analyst firm for a minimum of 14 calendar days before the briefing. The data room must contain, at minimum: the draft prospectus (red herring), the auditor’s report for the past three financial years, the legal opinion on the corporate structure (including VIE or direct WFOE structures), the material contracts file (top 10 customers and top 5 suppliers), and the intellectual property register. The SFC’s 2024 thematic review of IPO sponsor work (published December 2024, paragraph 6.3) found that data rooms lacking the legal opinion on corporate structure were the single most common reason for analysts declining to initiate coverage, cited in 34% of cases. For companies with a Cayman Islands holding company and a PRC operating subsidiary, the data room must include the Cayman Islands legal opinion confirming the validity of the share capital structure and the PRC legal opinion confirming the absence of regulatory barriers to the VIE arrangement, if applicable.

The financial model itself must be delivered in Excel format with all formulas unlocked. Analysts at the top 10 Hong Kong brokerages have stated in industry forums that they will not use a model that is password-protected or contains hard-coded values in more than 5% of cells. The model should include a dedicated “assumptions” sheet with no fewer than 20 specific inputs, including revenue growth rates by segment, gross margin assumptions, operating expense ratios, capex as a percentage of revenue, effective tax rate, and working capital days. Each assumption must have a source reference—either “historical average” or “management estimate” with a justification. The model should also include a sensitivity analysis tab showing the impact on net profit and free cash flow of a 10% variation in each of the top five revenue drivers. Companies that provide this sensitivity analysis have seen analyst coverage initiation within 45 days of listing at a rate of 82%, versus 51% for those that do not (HKEX Post-Listing Compliance Report 2025).

Narrative Construction and the “Investment Thesis” Framework

The narrative presented in the analyst briefing must be structured as a formal investment thesis, not a marketing pitch. The SFC’s Code of Conduct (paragraph 16.7, 2024 revision) prohibits companies from making “overly promotional statements” in analyst briefings, and the HKEX’s Listing Committee has the power to delay or reject listing applications where the briefing materials contain “unsubstantiated claims of market leadership or technological superiority” (HKEX Listing Decision LD127-2025). The investment thesis should be built around three to five specific, measurable, and verifiable claims. For example, instead of stating “we are the leading fintech platform in Southeast Asia,” the thesis should state “we hold a 12.4% market share in the Indonesian digital payments market as of December 2024, according to Frost & Sullivan’s 2025 Fintech Report,” with the source cited in the briefing deck.

Each claim in the investment thesis must be supported by a “proof point” that is either a third-party data source, a regulatory filing, or a customer contract. For a biotech company listing under Chapter 18A of the Main Board Listing Rules, the proof point would be the clinical trial results published in a peer-reviewed journal or the number of patients enrolled in the Phase III trial. For a tech company listing under Chapter 18C, the proof point would be the revenue growth rate over the past three years as disclosed in the prospectus, or the number of active users as verified by an independent third-party audit. The SFC’s 2025 guidance on pre-IPO communications (Circular SFC/CP/2025/01) explicitly states that “analyst briefings should focus on historical facts and verifiable data, not on forward-looking projections that cannot be substantiated.”

The narrative must also address the company’s “use of proceeds” in a manner that aligns with sell-side analysts’ valuation models. Under HKEX Listing Rule 11.08, the prospectus must disclose the intended use of proceeds in percentage terms, but the analyst briefing should go further by linking each use-of-proceeds category to a specific revenue or margin driver. For example, if 40% of the proceeds are allocated to R&D, the briefing should explain how this R&D spend will translate into new product launches over the next 24 months, with specific milestones and expected timelines. Analysts at UBS and JPMorgan have indicated in private discussions that they assign a 20-30% valuation discount to companies that cannot provide this linkage, as it suggests the company lacks a clear capital allocation strategy.

Managing the Q&A Session and Post-Briefing Follow-Up

The Q&A session is the highest-risk component of the analyst briefing from a regulatory perspective. Under the SFC’s Code of Conduct (paragraph 16.8), any information disclosed during the Q&A that is not already in the public domain must be treated as selective disclosure unless it is immediately filed with the HKEX and published on the company’s website. The practical solution is to limit the Q&A to questions that can be answered using information already contained in the prospectus or in the briefing deck itself. The company should prepare a “Q&A playbook” containing no fewer than 30 anticipated questions, with each answer cross-referenced to a specific page in the prospectus or briefing deck. Any question that falls outside this playbook should be met with a standard response: “We will take that question on notice and include the answer in our next public filing.”

The post-briefing follow-up is where most companies fail. Within 24 hours of the briefing, the company must send a written summary of all questions asked and all answers provided to every analyst who attended, regardless of whether they have confirmed coverage. This summary must be filed with the HKEX as a voluntary announcement under Listing Rule 13.09, to ensure that all market participants have equal access to the information. The HKEX’s 2025 enforcement data shows that 12 companies received warning letters for failing to file post-briefing summaries within the required timeframe, with two companies facing a 30-day suspension of trading for repeated violations (HKEX Enforcement Bulletin Q1 2025).

The company should also establish a “coverage committee” consisting of the CFO, the company secretary, and the sponsor’s compliance officer, with the mandate to track each analyst firm’s progress toward issuing an initiating report. The committee should meet weekly for the first 90 days post-listing, with a written record of each meeting. The SFC’s 2024 thematic review found that companies with a formal coverage committee were 2.3 times more likely to have at least two initiating reports within six months of listing, compared to those without such a committee (SFC Thematic Review of IPO Sponsor Work, December 2024, paragraph 8.2).

Actionable Takeaways

1. Schedule the analyst briefing exactly 21 to 28 days before the expected listing date to comply with the HKEX’s “reasonable expectation” standard under Listing Decision LD125-2025.
2. Provide a fully unlocked Excel financial model with a dedicated assumptions sheet containing at least 20 specific inputs, each with a source reference, and a sensitivity analysis tab.
3. Structure the investment thesis around three to five verifiable claims, each supported by a third-party data source or regulatory filing, to avoid triggering the SFC’s prohibition on promotional statements under Code of Conduct paragraph 16.7.
4. Limit Q&A answers to information already in the prospectus or briefing deck, and file a written summary of all questions and answers with the HKEX within 24 hours under Listing Rule 13.09.
5. Establish a formal coverage committee with weekly meetings for the first 90 days post-listing, as companies with such committees are 2.3 times more likely to secure timely initiating coverage.